Literature DB >> 7913849

Bone marrow transplants from peripheral blood.

T L Holyoake, I M Franklin.   

Abstract

Mesh：

Year:  1994        PMID： 7913849      PMCID： PMC2542633          DOI： 10.1136/bmj.309.6946.4

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Report on the European Workshop on Peripheral Blood Stem Cell Determination and Standardization--Mulhouse, France, February 6-8 and 14-15, 1992.

Authors:  E Wunder; H Sovalat; G Fritsch; F Silvestri; P Henon; S Serke
Journal:  J Hematother       Date:  1992

2.  Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.

Authors:  F Lobo; A Kessinger; J D Landmark; D M Smith; D D Weisenburger; R S Wigton; J O Armitage
Journal:  Bone Marrow Transplant       Date:  1991-11       Impact factor: 5.483

Review 3.  The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies.

Authors:  A Kessinger; J O Armitage
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

4.  Myelosuppression and "conventional" chemotherapy: what price, what benefit?

Authors:  G P Canellos; G D Demetri
Journal:  J Clin Oncol       Date:  1993-01       Impact factor: 44.544

5.  High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation.

Authors:  L B To; D N Haylock; R J Kimber; C A Juttner
Journal:  Br J Haematol       Date:  1984-11       Impact factor: 6.998

6.  Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  S Siena; M Bregni; B Brando; F Ravagnani; G Bonadonna; A M Gianni
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

7.  Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry.

Authors:  J G Bender; K L Unverzagt; D E Walker; W Lee; D E Van Epps; D H Smith; C C Stewart; L B To
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

8.  Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.

Authors:  M Bregni; M Magni; S Siena; M Di Nicola; G Bonadonna; A M Gianni
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

9.  Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells.

Authors:  C I Civin; L C Strauss; C Brovall; M J Fackler; J F Schwartz; J H Shaper
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

10.  Increase in circulating stem cells following chemotherapy in man.

Authors:  C M Richman; R S Weiner; R A Yankee
Journal:  Blood       Date:  1976-06       Impact factor: 22.113
View more
  6 in total

Review 1.  Haemopoietic growth factors.

Authors:  N J Ketley; A C Newland
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

2.  Bone marrow transplantation. Comparative data on quality of care and outcome are urgently needed.

Authors:  M Harding
Journal:  BMJ       Date:  1995-04-01

3.  Bone marrow transplants from peripheral blood.

Authors:  J A Snowden; J G Wright; J Peel; D A Winfield
Journal:  BMJ       Date:  1994-09-10

4.  Autografts of peripheral blood stem cells.

Authors:  C L Rist
Journal:  BMJ       Date:  1994-08-06

5.  Contamination of bone marrow transplants from peripheral blood.

Authors:  M Farrington; I Matthews; R Marcus; M A Scott; E Caffrey; C J Hunt
Journal:  BMJ       Date:  1994-10-08

6.  Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.

Authors:  P Pedrazzoli; C Perotti; G A Da Prada; F Bertolini; N Gibelli; L Torretta; M Battaglia; L Pavesi; P Preti; L Salvaneschi; G Robustelli della Cuna
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.